When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYOV - Myovant up 7% premarket on successful relugolix study
Myovant Sciences Ltd.
Myovant Sciences (NYSE:MYOV) is up 7% premarket on light volume in reaction to positive results from a Phase 3 clinical trial, SPIRIT 2, evaluating once-daily relugolix combo therapy (relugolix 40 mg plus estradiol 1.0 mg, and norethindrone acetate 0.5 mg) in women with endometriosis-related pain.
More news on: Myovant Sciences Ltd., Healthcare stocks news, Stocks on the move,